Ocular Therapeut
(OCUL)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Sales | 17,403 | 4,227 | 1,990 | 1,923 | 1,887 |
| Cost of Goods | 2,083 | 2,325 | 465 | 457 | 443 |
| Gross Profit | 15,320 | 1,902 | 1,525 | 1,466 | 1,444 |
| Operating Expenses | 78,250 | 88,029 | 61,108 | 63,846 | 45,213 |
| Operating Income | -62,847 | -85,802 | -59,118 | -61,923 | -43,326 |
| Interest Expense | 6,768 | 6,101 | 1,739 | 1,892 | 1,680 |
| Other Income | -86,021 | 5,531 | 879 | 429 | 303 |
| Pre-tax Income | -155,636 | -86,372 | -59,978 | -63,386 | -44,703 |
| Net Income Continuous | -155,636 | -86,372 | -59,978 | -63,386 | -44,703 |
| Net Income | $-155,636 | $-86,372 | $-59,978 | $-63,386 | $-44,703 |
| EPS Basic Total Ops | -2.56 | -1.91 | -1.57 | -2.20 | -1.80 |
| EPS Basic Continuous Ops | -2.56 | -1.91 | -1.57 | -2.20 | -1.80 |
| EPS Diluted Total Ops | -2.56 | -1.91 | -1.57 | -2.20 | -1.80 |
| EPS Diluted Continuous Ops | -2.56 | -1.91 | -1.57 | -2.20 | -1.80 |
| EPS Diluted Before Non-Recurring Items | -1.14 | -2.01 | N/A | N/A | N/A |
| EBITDA(a) | $-60,074 | $-83,272 | $-56,832 | $-60,281 | $-42,259 |